FDA Clears Avinger's Wildcat Catheter for CTO Treatment
August 16, 2011—Avinger, Inc. (Redwood City, CA) has received 510(k) clearance from the US Food and Drug Administration to market its Wildcat catheter for crossing chronic total occlusions (CTOs) to allow treatment via balloon angioplasty, stent, or atherectomy for peripheral artery disease.
